Clinical Trial Update: A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation [NA]

View source ↗

Summary

A completed clinical trial comparing AirSeal integrated insufflation system with conventional insufflation for renal cell carcinoma; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of California, Irvine | Conditions: Renal Cell Carcinoma | NA | Status: COMPLETED | Results posted: 2018-02-14